1 |
Naphthyridine derivatives as inhibitors of hypoxia inducible factor (HIF) hydroxylase |
US14581592 |
2014-12-23 |
US09271970B2 |
2016-03-01 |
Danny Ng; Michael P. Arend; Lee A. Flippin |
The present disclosure relates to novel compounds, methods, and compositions capable of inhibiting HIF hydroxylase enzyme activity, thereby increasing the stability and/or activity of hypoxia inducible factor (HIF). |
2 |
Naphthyridine derivatives as inhibitors of Hypoxia inducible factor (HIF) hydroxylase |
US15043286 |
2016-02-12 |
US09695170B2 |
2017-07-04 |
Danny Ng; Michael P. Arend; Lee A. Flippin |
The present disclosure relates to novel compounds, methods, and compositions capable of inhibiting HIF hydroxylase enzyme activity, thereby increasing the stability and/or activity of hypoxia inducible factor (HIF). |
3 |
NAPHTHYRIDINE DERIVATIVES AS INHIBITORS OF HYPOXIA INDUCIBLE FACTOR (HIF) HYDROXYLASE |
US15043286 |
2016-02-12 |
US20160159796A1 |
2016-06-09 |
Danny Ng; Michael P. Arend; Lee A. Flippin |
The present disclosure relates to novel compounds, methods, and compositions capable of inhibiting HIF hydroxylase enzyme activity, thereby increasing the stability and/or activity of hypoxia inducible factor (HIF). |
4 |
NAPHTHYRIDINE DERIVATIVES AS INHIBITORS OF HYPOXIA INDUCIBLE FACTOR (HIF) HYDROXYLASE |
US14581592 |
2014-12-23 |
US20150174110A1 |
2015-06-25 |
Danny Ng; Michael P. Arend; Lee A. Flippin |
The present disclosure relates to novel compounds, methods, and compositions capable of inhibiting HIF hydroxylase enzyme activity, thereby increasing the stability and/or activity of hypoxia inducible factor (HIF). |
5 |
Naphthyridine derivatives as inhibitors of hypoxia inducible factor (HIF) hydroxylase |
US13983025 |
2012-02-01 |
US08921389B2 |
2014-12-30 |
Danny Ng; Michael P. Arend; Lee A. Flippin |
The present disclosure relates to novel compounds, methods, and compositions capable of inhibiting HIF hydroxylase enzyme activity, thereby increasing the stability and/or activity of hypoxia inducible factor (HIF). |
6 |
NAPHTHYRIDINE DERIVATIVES AS INHIBITORS OF HYPOXIA INDUCIBLE FACTOR (HIF) HYDROXYLASE |
US13983025 |
2012-02-01 |
US20140088101A1 |
2014-03-27 |
Danny Ng; Michael P. Arend; Lee A. Flippin |
The present disclosure relates to novel compounds, methods, and compositions capable of inhibiting HIF hydroxylase enzyme activity, thereby increasing the stability and/or activity of hypoxia inducible factor (HIF). |
7 |
NAPHTHYRIDINE DERIVATIVES AS INHIBITORS OF HYPOXIA INDUCIBLE FACTOR (HIF) HYDROXYLASE |
EP12704581.3 |
2012-02-01 |
EP2670750A1 |
2013-12-11 |
NG, Danny; AREND, Michael P.; FLIPPIN, Lee A. |
The present disclosure relates to novel compounds, methods, and compositions capable of inhibiting HIF hydroxylase enzyme activity, thereby increasing the stability and/or activity of hypoxia inducible factor (HIF). |
8 |
NAPHTHYRIDINE DERIVATIVES AS INHIBITORS OF HYPOXIA INDUCIBLE FACTOR |
EP12704581.3 |
2012-02-01 |
EP2670750B1 |
2016-09-14 |
NG, Danny; AREND, Michael P.; FLIPPIN, Lee A. |
|